Japan registry to use of Promus element in acute coronary syndrome patients
Not Applicable
Recruiting
- Conditions
- Acute Coronary Syndrome
- Registration Number
- JPRN-UMIN000010850
- Lead Sponsor
- Society of ACS Intervention and Therapeutics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
F)Enrolled in another study (excluding PMS) or receiving any treatment affected the registry. G)Pregnant or possibility of pregnancy in the registry period. H)Known hypersensitivity reaction to everolimus, polymer, metal I)Known hypersensitivity reaction to antiplatelet J)Improper functioning of the liver K)Kidney malfunction(>=3.0mg/dl serum creatinine level) or dialysis treatment. L)Active cancer M)Lesion in saphenous vein graft N)cardiogenic shock by clinical assessment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiac event including cardiac death, myocardial infarction, and target lesion revascularization at 12 mont
- Secondary Outcome Measures
Name Time Method TLR at 9 month/24 month TVR at 9 month/24month MI at 9 month/24 month Death at 9 month/24 month MACE at 9 month/24 month Stent thrombosis (acute, sub-acute, late, and very late) defined by Academic Research Consortium (ARC) at 9 month/ 24 month